BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

BenevolentAI

BenevolentAI logo

Founded
2013
Patents
38
Clinical Trials
1
Publications
40

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discoverytowards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.

Become a Member to view additional information about this company

Posts Mentioning This Company

Biopharma Insights
Video gallery
Biopharma Insights